Pfizer’s Paxlovid Excluded from China’s NRDL Amid Price Dispute
The National Reimbursement Drug List (NRDL) negotiations have concluded, with Pfizer’s (NYSE: PFE) COVID-19 therapy...
Policy / Regulatory
China Strengthens COVID-19 Prevention and Control in Rural Areas
China has intensified its COVID-19 prevention and control measures in rural areas, with the State...
China’s National Health Commission Releases Updated COVID-19 Treatment Plan
The National Health Commission (NHC) has released the 10th edition of the national COVID-19 Diagnosis...
NMPA Strengthens Oversight of COVID-19 Drugs and Home Treatment Guidelines
The National Medical Products Administration (NMPA) has released a notification aimed at enhancing the quality...
China’s NHC and NATCM Launch Integrated Pain Management Pilot Plan
The National Health Commission (NHC) and the National Administration of Traditional Chinese Medicine (NATCM) have...
CDE Releases 65th Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 65th batch of chemical generic reference...
Jiangxi Leads 16-Province VBP Alliance with Winning Bids Announced
The Jiangxi Province Healthcare Security Administration has released a notification regarding the winning bids of...
NHSA and CNIPA Issue Opinions on Strengthening IP Protection in Drug Procurement
The National Healthcare Security Administration (NHSA) and the China National Intellectual Property Administration (CNIPA) have...
China Downgrades COVID-19 from Class A to Class B Infectious Disease
The National Health Commission (NHC) has issued a notice downgrading COVID-19 from a Class A...
Sichuan Healthcare Security Administration Announces VBP for Oral Implant Systems
The Sichuan Provincial Healthcare Security Administration has released a notification regarding the inter-provincial alliance volume-based...
NHSA Orders Investigation into Unreasonable Medical Insurance Restrictions
The National Healthcare Security Administration (NHSA) has released a notification to medical insurance departments across...
NMPA and GAC Release Notification on Import and Export Management of Narcotic Drugs
The National Medical Products Administration (NMPA) and the General Administration of Customs (GAC) have released...
Shanghai Outlines Plans to Boost Healthcare and Pharma Industry
Liu Wei, director of the market orders and trade division of the Shanghai Commerce Commission,...
PCAOB Report Signals Relief for US-Listed Chinese Biotechs
A report issued last week by the US Public Company Accounting Oversight Board (PCAOB) indicated...
WuXi Biologics’ Shanghai Subsidiary Removed from US UVL
China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) announced that its...
Liaoning Publishes Fourth Round of Volume-Based Procurement Winning Bids
The Liaoning drug and medical consumables centralized procurement website has published the fourth round of...
China’s COVID-19 Vaccination Second Booster Shot Plan Released
The National Health Commission website indicates that the COVID-19 Joint Prevention and Control Mechanism of...
Beijing Releases COVID-19 Infection Drug List to Address Stocking Issues
The Beijing Municipal Health Commission formulated and released the “COVID-19 infection drug list” (first edition),...
China’s State Council Boosts Internet Medical Services Amid COVID-19
The State Council released a notification in relation to the COVID-19 pandemic, seeking to ramp...
Northeast Pharmaceutical Fined RMB 133M for Monopoly Selling
Northeast Pharmaceutical Co., Ltd (SHE: 000597) was fined RMB 133 million (USD 19m) by the...